Articles tagged with "Drugs & Pharmaceuticals"

Sort by

Medicines Discovery Catapult partners LifeArc for biomarker R&D

May 9, 2019
Medicines Discovery Catapult and LifeArc have announced partnerships to advance R&D in biomarker discovery and proteomics technology. The organisations will develop biomarkers that detect the safety of novel drug molecules...

Making a value judgement

May 7, 2019
Bioethics has become a global endeavour – and a good thing too says Catherine Joynson. As we push the boundaries of what we do with biology, we need to ask...

First US based human trial of CRISPR

May 1, 2019
The University of Pennsylvania has announced it has started the first formal US human trial using the technique. Two patients, one with multiple myeloma and one with sarcoma, both of...

One at a time

April 29, 2019
Watching biological processes one molecule at a time is an incredibly difficult task… but it is getting easier says Dr Joanna Andrecka, and it could turn drug discovery on its...

Running interference

April 23, 2019
Immuno-Oncology is considered a vital front in the battle against cancer, but will current approaches get us there? Dr Geert Cauwenbergh takes us through some pitfalls and tells us how...

An edit for good?

April 9, 2019
Gene editing could allow incredible crop improvements, with the potential to reduce the harmful impact of agrochemicals on biodiversity while boosting yield. However, the recent European Court of Justice ruling...

Mutation found in drug-resistant fungus

April 4, 2019
A newly identified genetic mutation in a drug resistant fungus may help in the fight against antimicrobial resistance.Researchers from the US and the UK found a novel form of resistance...

Making a human connection

March 25, 2019
As organ-on-a-chip technology advances at pace, the next step is to connect them and understand a new drug’s effects on the entire human body – without having to go to...

The era of monetised DNA?

February 21, 2019
The next generation of genomics platforms will usher in a personalised healthcare revolution, but will they also allow individuals to monetise their DNA? You better believe it says Dr Axel...

Cannabis-based dementia treatment

February 15, 2019
The first cannabis-based medicine to be licensed in the UK will be trialled as a treatment for people living with dementia.Alzheimer’s Research UK is committing nearly £300,000 for the trial...

Pin It on Pinterest